A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial

Name: A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial
License: Public Domain

Cardresearch

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

long covid-19 syndrome, chronic fatigue syndrome

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 234372
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.